These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 30895610)

  • 21. Neurosteroid-sensitive δ-GABA
    Joshi S; Rajasekaran K; Williamson J; Kapur J
    Epilepsia; 2017 Mar; 58(3):494-504. PubMed ID: 28452419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurosteroids: endogenous role in the human brain and therapeutic potentials.
    Reddy DS
    Prog Brain Res; 2010; 186():113-37. PubMed ID: 21094889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy.
    Reddy DS; Rogawski MA
    J Pharmacol Exp Ther; 2000 Sep; 294(3):909-15. PubMed ID: 10945840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy.
    Reddy DS
    Front Endocrinol (Lausanne); 2011; 2():38. PubMed ID: 22654805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women.
    Reddy DS
    J Neuroendocrinol; 2022 Feb; 34(2):e13028. PubMed ID: 34506047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced neurosteroid potentiation of GABA
    Joshi S; Roden WH; Kapur J; Jansen LA
    Ann Clin Transl Neurol; 2020 Apr; 7(4):527-542. PubMed ID: 32243088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurosteroids and Seizure Activity.
    Miziak B; Chrościńska-Krawczyk M; Czuczwar SJ
    Front Endocrinol (Lausanne); 2020; 11():541802. PubMed ID: 33117274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.
    Carter RB; Wood PL; Wieland S; Hawkinson JE; Belelli D; Lambert JJ; White HS; Wolf HH; Mirsadeghi S; Tahir SH; Bolger MB; Lan NC; Gee KW
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1284-95. PubMed ID: 9067315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility.
    Reddy DS; Rogawski MA
    J Neurosci; 2002 May; 22(9):3795-805. PubMed ID: 11978855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurosteroid Agonist at GABAA receptor induces persistent neuroplasticity in VTA dopamine neurons.
    Vashchinkina E; Manner AK; Vekovischeva O; den Hollander B; Uusi-Oukari M; Aitta-Aho T; Korpi ER
    Neuropsychopharmacology; 2014 Feb; 39(3):727-37. PubMed ID: 24077066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety.
    Maguire JL; Stell BM; Rafizadeh M; Mody I
    Nat Neurosci; 2005 Jun; 8(6):797-804. PubMed ID: 15895085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced tonic GABA current in normotopic and hilar ectopic dentate granule cells after pilocarpine-induced status epilepticus.
    Zhan RZ; Nadler JV
    J Neurophysiol; 2009 Aug; 102(2):670-81. PubMed ID: 19474175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of catamenial epilepsy.
    Reddy DS
    Methods Find Exp Clin Pharmacol; 2004 Sep; 26(7):547-61. PubMed ID: 15538544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmentation of endogenous neurosteroid synthesis alters experimental status epilepticus dynamics.
    Lucchi C; Costa AM; Senn L; Messina S; Rustichelli C; Biagini G
    Epilepsia; 2020 Sep; 61(9):e129-e134. PubMed ID: 32929741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virally-induced expression of GABA
    Sun Y; Peng Z; Wei X; Zhang N; Huang CS; Wallner M; Mody I; Houser CR
    Prog Neurobiol; 2022 Nov; 218():102337. PubMed ID: 35934131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavior and physiology of mice lacking the GABAA-receptor delta subunit.
    Spigelman I; Li Z; Banerjee PK; Mihalek RM; Homanics GE; Olsen RW
    Epilepsia; 2002; 43 Suppl 5():3-8. PubMed ID: 12121286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy.
    Lattanzi S; Riva A; Striano P
    Expert Rev Neurother; 2021 Nov; 21(11):1317-1332. PubMed ID: 33724128
    [No Abstract]   [Full Text] [Related]  

  • 38. Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic.
    Reddy DS
    J Pharmacol Exp Ther; 2024 Jan; 388(2):273-300. PubMed ID: 37977814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats.
    Nguyen DA; Stone MF; Schultz CR; de Araujo Furtado M; Niquet J; Wasterlain CG; Lumley LA
    J Pharmacol Exp Ther; 2024 Jan; 388(2):376-385. PubMed ID: 37770198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acutely increasing δGABA(A) receptor activity impairs memory and inhibits synaptic plasticity in the hippocampus.
    Whissell PD; Eng D; Lecker I; Martin LJ; Wang DS; Orser BA
    Front Neural Circuits; 2013; 7():146. PubMed ID: 24062648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.